Viewing Study NCT06516042



Ignite Creation Date: 2024-10-26 @ 3:35 PM
Last Modification Date: 2024-10-26 @ 3:35 PM
Study NCT ID: NCT06516042
Status: NOT_YET_RECRUITING
Last Update Posted: None
First Post: 2024-07-11

Brief Title: Targeted Antimalarial Drug Administration for Seasonal Migrant Populations in Amhara Region Ethiopia
Sponsor: None
Organization: None

Study Overview

Official Title: Effectiveness Feasibility and Acceptability of Targeted Antimalarial Interventions for Seasonal Migrant Populations in Metema District Amhara Region Ethiopia
Status: NOT_YET_RECRUITING
Status Verified Date: 2024-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of the study is to assess the effectiveness feasibility and acceptability of targeted drug administration for seasonal migrant populations in Metema District Amhara Region Ethiopia
Detailed Description: A cluster randomized controlled trial will be used to evaluate the effectiveness feasibility and acceptability of targeted antimalarial drug administration TDA for seasonal migrant farmworkers in the Delello farm sites in Metema district Amhara Region Individual farm sites will be randomized 111 to either of two intervention options or control where all farmworkers at intervention sites will receive either two or three rounds of dihydro artemisinin piperaquine over the primary farming season

All study farm-sites will receive enhanced case management conducted by mobile health teams throughout the study period

Cross-sectional surveys will be conducted in all arms at baseline and 4 to 6 weeks following the third round of TDA to assess the effectiveness of the intervention for reducing parasite prevalence

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None